Skip to search boxSkip to navigationSkip to main content

SARM is required for neuronal injury and cytokine production in response to central nervous system viral infection

  • Ying Ju Hou
    ,
  • Rebecca Banerjee
    ,
  • Bobby Thomas
    ,
  • Carl Nathan
    ,
  • Adolfo Garciá-Sastre
    ,
  • Aihao Ding
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Four of the five members of the Toll/IL-1R domain-containing adaptor family are required for signaling downstream of TLRs, promoting innate immune responses against different pathogens. However, the role of the fifth member of this family, sterile α and Toll/IL-1R domain-containing 1 (SARM), is unclear. SARM is expressed primarily in the CNS where it is required for axonal death. Studies in Caenorhabditis elegans have also shown a role for SARM in innate immunity. To clarify the role of mammalian SARM in innate immunity, we infected SARM-/- mice with a number of bacterial and viral pathogens. SARM-/- mice show normal responses to Listeria monocytogenes, Mycobacterium tuberculosis, and influenza virus, but show dramatic protection from death after CNS infection with vesicular stomatitis virus. Protection correlates with reduced CNS injury and cytokine production by nonhematopoietic cells, suggesting that SARM is a positive regulator of cytokine production. Neurons and microglia are the predominant source of cytokines in vivo, supporting a role for SARM as a link between neuronal injury and innate immunity.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 875-883 (9 pages)

Journal (Volume, Issue Number)

Journal of Immunology (Volume 191, Issue 2)

Publication milestones

  • Published - 07/15/2013

Publication status

Published - 07/15/2013

ISSN

0022-1767

Publication IDs

  • Scopus: 84880117379
  • PubMed: 23749635

Publication metrics

Metrics

SciVal
FWCI
1.05
SciVal
Author count
7
SciVal
citations
31
SciVal
Paper percentile
87
Scopus
citations
Fractional count
1
Fractional count
0.14
Fractional count
6
Fractional count
0.86
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
78
Citation count
52

Funding Details

FunderFunding number
NIAID
U19AI083025